Daewoong Pharma대웅제약

Credit rating

• A+stable outlookKorea Ratings · corporate bonds · Rated Aug 14, 2026
• A+stable outlookNICE Investors Service · corporate bonds · Rated Aug 14, 2026

Bonds outstanding

₩244B in 3 bonds

1. ≤6 months₩154B
2. 6–12 months—
3. 1–2 years₩90B
4. 2–3 years—
5. 3–5 years—
6. Over 5 years—

We read bond filings from Oct 25, 2021; older bonds may be missing.

Due soon vs cash

Due in 6 months

₩154B

Due in 12 months

₩154B

Cash and equivalents

₩155B

Cash from the 2026 H1 statements

How it has moved with rates and the won

Average move of the shares on days the factor changed, over the last year. Describes the past, not a forecast.

• −0.15% per 10 bp rise in KTB 3yweak link · correlation -0.02 over 253 days
• +0% per 1% rise in USD/KRWweak link · correlation 0.00 over 253 days